Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP)
Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP)
复制标题
DOI:
10.1007/s00246-020-02340-z
复制
发表时间:
2020-06-01
影响因子:
1.6
通讯作者:
Dahdah, Nagib
中科院分区:
文献类型:
--
作者:
Desjardins, Laurent;Dionne, Audrey;Dahdah, Nagib
The N-terminal proBNP (NT-proBNP), produced by cardiomyocytes, has several reported utilities and associations in acute Kawasaki disease (KD). The objective of this study is to examine the relationship between serum values of NT-proBNP at time of KD diagnosis with cardiac systolic, diastolic function and electrocardiographic changes, at onset of the disease and during the first year of follow-up. KD was diagnosed in 127 children between March 2007 and July 2014, mean diagnostic age 3.5 +/- 2.9 years. Coronary artery maximumzscore was 2.6 +/- 2.8 (range - 0.6 to + 18.9), with giant aneurysm in 5/122 (4.1%). Age-adjusted NT-proBNP was 2.6 +/- 1.6zscore, 78/122 (63.9%) > 2.0. There was a crescendo correlation between onset NT-proBNPzscore and C-Reactive protein (CRP) serum levels (slope + 0.49,p < 0.001). There was a crescendo correlation between NT-proBNPzscore and indexed left ventricular (LV) mass (slope + 1.86,p = 0.02), LV diastolic function parameterE/e ' ratio (slope + 0.31,p = 0.04) and a decrescendo correlation with age-adjusted LV shortening fraction (SF) (- 0.63,p = 0.02). Lower SFzscore, higher left ventricular mass index andE/e ' ratio were associated with higher NT-proBNPzscore, but without correlation with CRP levels. Within 2-3 months from the onset of the disease, there was a resolution of the systolic dysfunction. Electrocardiographic parameter changes were associated with decreased LV shortening fraction but not with NT-proBNP. KD patients with elevated NT-proBNP at onset have sub-clinical myocardial involvement and might benefit from follow-up and continued evaluation, even in the absence of coronary artery involvement.